These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 2407353)
1. Identification and management of potential heart transplant recipients. Jessup M; Brozena SC Cardiol Clin; 1990 Feb; 8(1):11-21. PubMed ID: 2407353 [TBL] [Abstract][Full Text] [Related]
2. Restrictive criteria for heart transplantation candidacy maximize survival of patients with advanced heart failure. Frigerio M; Gronda EG; Mangiavacchi M; Andreuzzi B; Colombo T; De Vita C; Oliva F; Quaini E; Pellegrini A J Heart Lung Transplant; 1997 Feb; 16(2):160-8. PubMed ID: 9059927 [TBL] [Abstract][Full Text] [Related]
3. Selection and treatment of candidates for heart transplantation. Costanzo MR Semin Thorac Cardiovasc Surg; 1996 Apr; 8(2):113-25. PubMed ID: 8672564 [TBL] [Abstract][Full Text] [Related]
4. [Surgical therapy of end-stage heart failure. State of the art 2006]. Klotz S; Loeher A; Drees G; Scheld HH Herz; 2006 Aug; 31(5):445-54. PubMed ID: 16944064 [TBL] [Abstract][Full Text] [Related]
5. Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure. Gavazzi A; Berzuini C; Campana C; Inserra C; Ponzetta M; Sebastiani R; Ghio S; Recusani F J Heart Lung Transplant; 1997 Jul; 16(7):774-85. PubMed ID: 9257260 [TBL] [Abstract][Full Text] [Related]
6. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group. McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290 [TBL] [Abstract][Full Text] [Related]
7. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy. John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167 [TBL] [Abstract][Full Text] [Related]
8. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Lietz K; Long JW; Kfoury AG; Slaughter MS; Silver MA; Milano CA; Rogers JG; Naka Y; Mancini D; Miller LW Circulation; 2007 Jul; 116(5):497-505. PubMed ID: 17638928 [TBL] [Abstract][Full Text] [Related]
9. Study of muscular and ventricular function in dynamic cardiomyoplasty: a ten-year follow-up. Chachques JC; Berrebi A; Hernigou A; Cohen-Solal A; Lavergne T; Marino JP; D'Attellis N; Bensasson D; Carpentier A J Heart Lung Transplant; 1997 Aug; 16(8):854-68. PubMed ID: 9286778 [TBL] [Abstract][Full Text] [Related]
10. Does cardiac resynchronisation therapy improve survival and quality of life in patients with end-stage heart failure? Turley AJ; Raja SG; Salhiyyah K; Nagarajan K Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1141-6. PubMed ID: 18541605 [TBL] [Abstract][Full Text] [Related]
11. Improving outcomes with long-term "destination" therapy using left ventricular assist devices. Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385 [TBL] [Abstract][Full Text] [Related]
12. Cardiac transplantation: candidate identification, evaluation, and management. McCalmont V; Ohler L Crit Care Nurs Q; 2008; 31(3):216-29; quiz 230-1. PubMed ID: 18574369 [TBL] [Abstract][Full Text] [Related]
13. Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999. Smits JM; Vanhaecke J; Haverich A; de Vries E; Smith M; Rutgrink E; Ramsoebhag A; Hop A; Persijn G; Laufer G Clin Transpl; 2003; ():89-100. PubMed ID: 15387100 [TBL] [Abstract][Full Text] [Related]
14. Sex and left ventricular volume predict survival in heart transplant candidates with peak oxygen uptake between ten and fourteen milliliters per kilogram per minute. Di Salvo TG; Koelling TM; Muller-Ehmsen J; Schmidt U; Semigran MJ; Dec GW J Heart Lung Transplant; 1997 Aug; 16(8):869-77. PubMed ID: 9286779 [TBL] [Abstract][Full Text] [Related]
15. Left ventricular assist devices as destination therapy: a new look at survival. Park SJ; Tector A; Piccioni W; Raines E; Gelijns A; Moskowitz A; Rose E; Holman W; Furukawa S; Frazier OH; Dembitsky W J Thorac Cardiovasc Surg; 2005 Jan; 129(1):9-17. PubMed ID: 15632819 [TBL] [Abstract][Full Text] [Related]
16. [Alternative approaches in the end-stage heart failure]. Durdu S; Akar R; Cavolli R; Eren NT; Corapçioğlu T; Uçanok K; Ozyurda U Anadolu Kardiyol Derg; 2003 Sep; 3(3):252-60. PubMed ID: 12967894 [TBL] [Abstract][Full Text] [Related]
17. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates. Zimpfer D; Zrunek P; Roethy W; Czerny M; Schima H; Huber L; Grimm M; Rajek A; Wolner E; Wieselthaler G J Thorac Cardiovasc Surg; 2007 Mar; 133(3):689-95. PubMed ID: 17320566 [TBL] [Abstract][Full Text] [Related]
18. [Modern therapy of cardiac insufficiency]. Stojsić D; Jelkić N Med Pregl; 1999; 52(3-5):113-24. PubMed ID: 10518395 [TBL] [Abstract][Full Text] [Related]